Amygdalar CB2 cannabinoid receptor mediates fear extinction deficits promoted by orexin-A/hypocretin-1 Biomedicine and Pharmacotherapy May 2022;149
Date
05/01/2022
DOI
10.1016/j.biopha.2022.112925Scopus ID
2-s2.0-85127815071 (requires institutional sign-in at Scopus site)
11 CitationsAuthor List
Ten-Blanco M, Flores Á, Pereda-Pérez I, Piscitelli F, Izquierdo-Luengo C, Cristino L, Romero J, Hillard CJ, Maldonado R, Di Marzo V, Berrendero F
Author
Cecilia J. Hillard PhD Associate Dean, Center Director, Professor in the Pharmacology and Toxicology department at Medical College of Wisconsin